VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma
- 1 September 2004
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 94 (3) , 630-635
- https://doi.org/10.1016/j.ygyno.2004.05.056
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implicationsThe Lancet Oncology, 2001
- Clinical implications of expression of vascular endothelial growth factor in metastatic lesions of ovarian cancersBritish Journal of Cancer, 2001
- Vascular Endothelial Growth Factor C Gene Expression Is Closely Related to Invasion Phenotype in Gynecological Tumor CellsGynecologic Oncology, 2001
- Vascular endothelial growth factor and interleukin-8 in ovarian cystic pathologyFertility and Sterility, 2001
- Molecular Biology of the VEGF and the VEGF Receptor FamilySeminars in Thrombosis and Hemostasis, 2000
- Role of Vascular Endothelial Growth Factor in Ovarian CancerThe American Journal of Pathology, 1998
- Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levelsBritish Journal of Cancer, 1997
- The Expression of Vascular Endothelial Growth Factor and Transforming Growth Factor-β Associates With Angiogenesis in Epithelial Ovarian CancerInternational Journal of Gynecological Pathology, 1997
- Significance of Vascular Endothelial Growth Factor/Vascular Permeability Factor for Solid Tumor Growth, and Its Inhibition by the AntibodyBiochemical and Biophysical Research Communications, 1993
- Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of ProteinsEndocrine Reviews, 1992